CN111166683A - Fullerene anti-aging antioxidant beauty and skin care cosmetic and preparation method thereof - Google Patents
Fullerene anti-aging antioxidant beauty and skin care cosmetic and preparation method thereof Download PDFInfo
- Publication number
- CN111166683A CN111166683A CN201911385056.2A CN201911385056A CN111166683A CN 111166683 A CN111166683 A CN 111166683A CN 201911385056 A CN201911385056 A CN 201911385056A CN 111166683 A CN111166683 A CN 111166683A
- Authority
- CN
- China
- Prior art keywords
- aging
- skin
- fullerene
- skin care
- cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 118
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 title claims abstract description 107
- 229910003472 fullerene Inorganic materials 0.000 title claims abstract description 107
- 239000002537 cosmetic Substances 0.000 title claims abstract description 58
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 33
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 31
- 230000003796 beauty Effects 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000203 mixture Substances 0.000 claims abstract description 40
- 230000003064 anti-oxidating effect Effects 0.000 claims abstract description 29
- -1 acetyl chitosamine Chemical compound 0.000 claims abstract description 21
- 235000016709 nutrition Nutrition 0.000 claims abstract description 19
- 230000032683 aging Effects 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- 238000001816 cooling Methods 0.000 claims description 31
- 235000006708 antioxidants Nutrition 0.000 claims description 27
- 239000000686 essence Substances 0.000 claims description 27
- 230000002829 reductive effect Effects 0.000 claims description 18
- 239000006071 cream Substances 0.000 claims description 17
- 239000000126 substance Substances 0.000 claims description 14
- 239000006210 lotion Substances 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 11
- 230000001804 emulsifying effect Effects 0.000 claims description 10
- 230000035764 nutrition Effects 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 9
- 239000003755 preservative agent Substances 0.000 claims description 8
- 238000007599 discharging Methods 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 230000001502 supplementing effect Effects 0.000 claims description 7
- 230000002335 preservative effect Effects 0.000 claims description 5
- 238000004090 dissolution Methods 0.000 claims description 3
- 238000004945 emulsification Methods 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 239000008406 cosmetic ingredient Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 26
- 239000000284 extract Substances 0.000 abstract description 18
- 230000037303 wrinkles Effects 0.000 abstract description 18
- 240000004246 Agave americana Species 0.000 abstract description 14
- 230000003020 moisturizing effect Effects 0.000 abstract description 14
- 102000008186 Collagen Human genes 0.000 abstract description 13
- 108010035532 Collagen Proteins 0.000 abstract description 13
- 229920001436 collagen Polymers 0.000 abstract description 13
- 230000037394 skin elasticity Effects 0.000 abstract description 13
- WSGCRSMLXFHGRM-DEVHWETNSA-N (2s)-2-[[(2s)-6-amino-2-[[(2s,3r)-2-[[(2s,3r)-2-[[(2s)-6-amino-2-(hexadecanoylamino)hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxybutanoyl]amino]hexanoyl]amino]-3-hydroxypropanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O WSGCRSMLXFHGRM-DEVHWETNSA-N 0.000 abstract description 10
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 abstract description 8
- 230000006378 damage Effects 0.000 abstract description 5
- 239000002932 luster Substances 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 105
- 239000012071 phase Substances 0.000 description 42
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 19
- 238000012360 testing method Methods 0.000 description 17
- 239000003921 oil Substances 0.000 description 13
- 235000019198 oils Nutrition 0.000 description 13
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 150000003254 radicals Chemical class 0.000 description 12
- 206010020751 Hypersensitivity Diseases 0.000 description 11
- 208000026935 allergic disease Diseases 0.000 description 11
- 230000009759 skin aging Effects 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 10
- 230000001815 facial effect Effects 0.000 description 10
- 238000009472 formulation Methods 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 230000007815 allergy Effects 0.000 description 9
- 230000001153 anti-wrinkle effect Effects 0.000 description 9
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 description 8
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 8
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 8
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 description 8
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 description 8
- 235000004032 Centella asiatica Nutrition 0.000 description 7
- 244000146462 Centella asiatica Species 0.000 description 7
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 7
- 239000000498 cooling water Substances 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 6
- 235000008754 Agave americana Nutrition 0.000 description 6
- 239000004475 Arginine Substances 0.000 description 6
- 229920002385 Sodium hyaluronate Polymers 0.000 description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 6
- 235000019437 butane-1,3-diol Nutrition 0.000 description 6
- 230000003750 conditioning effect Effects 0.000 description 6
- 239000003974 emollient agent Substances 0.000 description 6
- 229960005323 phenoxyethanol Drugs 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 229940010747 sodium hyaluronate Drugs 0.000 description 6
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 239000007790 solid phase Substances 0.000 description 5
- 229940015975 1,2-hexanediol Drugs 0.000 description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000000049 pigment Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000003716 rejuvenation Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 3
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 241001135917 Vitellaria paradoxa Species 0.000 description 3
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 125000005456 glyceride group Chemical group 0.000 description 3
- 239000003906 humectant Substances 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 229940100554 isononyl isononanoate Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 3
- 229940049964 oleate Drugs 0.000 description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 3
- 229940100460 peg-100 stearate Drugs 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 229960004063 propylene glycol Drugs 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 3
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 208000002141 Pellagra Diseases 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 235000000539 Rosa canina Nutrition 0.000 description 2
- 240000008530 Rosa canina Species 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 239000008168 almond oil Substances 0.000 description 2
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 229940059958 centella asiatica extract Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 2
- 229940100524 ethylhexylglycerin Drugs 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- XYTHHAXRVHHXKO-JIUYZRCGSA-N 18-[(2r,3s,4r,5r)-4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxyoctadecanoic acid;ethanol Chemical compound CCO.COC1O[C@H](CO)[C@@H](OCCCCCCCCCCCCCCCCCC(O)=O)[C@H](O)[C@H]1O XYTHHAXRVHHXKO-JIUYZRCGSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- ILCOCZBHMDEIAI-UHFFFAOYSA-N 2-(2-octadecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCOCCO ILCOCZBHMDEIAI-UHFFFAOYSA-N 0.000 description 1
- VNXWANZMRATDQM-UHFFFAOYSA-N 2-(2-phenylethyl)benzene-1,3-diol Chemical compound OC1=CC=CC(O)=C1CCC1=CC=CC=C1 VNXWANZMRATDQM-UHFFFAOYSA-N 0.000 description 1
- UITSPQLTFPTHJZ-UHFFFAOYSA-N 2-[[3,4,5-tris(2-hydroxyethoxy)-6-methoxyoxan-2-yl]methoxy]ethanol Chemical compound COC1OC(COCCO)C(OCCO)C(OCCO)C1OCCO UITSPQLTFPTHJZ-UHFFFAOYSA-N 0.000 description 1
- ADOHEWVFRZKRHE-UHFFFAOYSA-N 2-acetyloxyethyl(trimethyl)azanium Chemical compound CC(=O)OCC[N+](C)(C)C.CC(=O)OCC[N+](C)(C)C ADOHEWVFRZKRHE-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- ICIDSZQHPUZUHC-UHFFFAOYSA-N 2-octadecoxyethanol Chemical compound CCCCCCCCCCCCCCCCCCOCCO ICIDSZQHPUZUHC-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- RMTFNDVZYPHUEF-XZBKPIIZSA-N 3-O-methyl-D-glucose Chemical compound O=C[C@H](O)[C@@H](OC)[C@H](O)[C@H](O)CO RMTFNDVZYPHUEF-XZBKPIIZSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 244000274847 Betula papyrifera Species 0.000 description 1
- 235000009113 Betula papyrifera Nutrition 0.000 description 1
- 235000009109 Betula pendula Nutrition 0.000 description 1
- 235000010928 Betula populifolia Nutrition 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- DBFHTTOOJDMDTI-KCMGSBMCSA-N C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C(CCCCCCCCCCCCCCCCC)(=O)O.C(CCCCCCCCCCCCCCCCC)(=O)O.CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO DBFHTTOOJDMDTI-KCMGSBMCSA-N 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241000167550 Centella Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 description 1
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- BVTHRGZMQHOCOL-UHFFFAOYSA-N OCC(O)(C1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O)CO Chemical compound OCC(O)(C1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O)CO BVTHRGZMQHOCOL-UHFFFAOYSA-N 0.000 description 1
- 206010033474 Pain of skin Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 240000003889 Piper guineense Species 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 235000010453 Pterocarpus marsupium Nutrition 0.000 description 1
- 240000008976 Pterocarpus marsupium Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 240000006661 Serenoa repens Species 0.000 description 1
- 235000005318 Serenoa repens Nutrition 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241001506047 Tremella Species 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- KQZNFGJQTPAURD-NBWQQBAWSA-N ascorbyl dipalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@H]1OC(=O)C(O)=C1O KQZNFGJQTPAURD-NBWQQBAWSA-N 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- PXTQQOLKZBLYDY-UHFFFAOYSA-N bis(2-ethylhexyl) carbonate Chemical compound CCCCC(CC)COC(=O)OCC(CC)CCCC PXTQQOLKZBLYDY-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 210000004900 c-terminal fragment Anatomy 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 235000012730 carminic acid Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229940099417 ceramide 2 Drugs 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- QKSIFUGZHOUETI-UHFFFAOYSA-N copper;azane Chemical compound N.N.N.N.[Cu+2] QKSIFUGZHOUETI-UHFFFAOYSA-N 0.000 description 1
- 239000002454 curcuma longa l. root extract Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229920000370 gamma-poly(glutamate) polymer Polymers 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000010457 gene scissor Methods 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940049294 glyceryl stearate se Drugs 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 238000002430 laser surgery Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229940090813 madecassoside Drugs 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000010487 meadowfoam seed oil Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 229940100485 methyl gluceth-10 Drugs 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 239000010018 saw palmetto extract Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229940098760 steareth-2 Drugs 0.000 description 1
- 229940100458 steareth-21 Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses a fullerene anti-aging antioxidant beauty and skin care cosmetic and a preparation method thereof, wherein the fullerene anti-aging antioxidant beauty and skin care cosmetic comprises (A)7.05-22.1 wt% of an anti-aging antioxidant nutritional composition and (B) optional common components in the skin care cosmetic. The anti-aging nutritional composition comprises: fullerene, phytosterol isostearate, acetyl chitosamine, hydrolyzed collagen, palmitoyl pentapeptide-4, nicotinamide, palmitoyl hexapeptide-8, agave stem extract, and herba Centellae extract. The invention has the beneficial effects that: the skin care product can obviously improve the effects of skin anti-aging, anti-oxidation, beauty and skin care products, and can greatly reduce the damage of free radicals to the skin of a human body, effectively delay the early aging of the skin, improve the skin moistening and moisturizing capability, enhance the skin elasticity, reduce the generation of fine wrinkles and young wrinkles, and simultaneously improve the skin color and luster.
Description
Technical Field
The invention relates to the field of skin care products, and mainly relates to a fullerene anti-aging antioxidant beauty and skin care cosmetic and a preparation method thereof.
Background
The human being enters the early aging stage after age 25, anti-aging is not a proper term for the elderly, and early 90 provides for the prevention of aging! With the development of skin care products with low age, the concepts of anti-aging, anti-saccharification and anti-oxidation are aroused, how enterprises meet different requirements of people of different age groups is the subject of research and development of effective anti-aging series products.
The damage to the skin of a human body is accelerated due to factors such as air pollution, invasion of environmental allergens, irradiation of sunlight, great pressure of modern work and life, unsafe cosmetics and the like, so that the early aging of the skin is accelerated, and anti-aging and anti-oxidation products are needed in the current market.
Although a plurality of anti-aging products are available on the market, the anti-aging cosmetic is developed according to aged people, the used raw materials are commonly used, anti-aging antioxidant active components are not well subdivided into different age groups, especially the skin of young people is fragile and easy to allergy, great care and caution are needed when a new product is developed, no addition and no allergy of the product are achieved, the effect nutrition combination plays an extremely good role in soothing and sensitizing, repairing and anti-aging effects on the skin of the face, and the anti-aging cosmetic is a problem to be solved in urgent research on the existing anti-aging antioxidant cosmetic with fullerene.
Therefore, the prior art still needs to be upgraded and improved.
Disclosure of Invention
Based on the above, the invention aims to provide the fullerene anti-aging antioxidant beauty and skin care cosmetic and the preparation method thereof, the cosmetic composition can obviously improve the skin anti-aging antioxidant beauty and skin care cosmetic effect, and the reasonable formula combination is designed according to different age groups, so that the skin aging is effectively delayed in advance, the skin moistening and moisturizing capability is improved, the skin elasticity is enhanced, the generation of fine wrinkles is reduced, and the skin color and the skin luster are improved. The fullerene anti-aging antioxidant beauty and skin care cosmetic provided by the invention contains any additional water, but does not exclude the water added in the adopted fullerene anti-aging antioxidant nutrition combination and a small amount or trace amount of water inevitably introduced in other components.
In order to realize the purpose of the invention, the invention adopts the following technical scheme:
the fullerene anti-aging antioxidant cosmetic for beauty and skin care is characterized by comprising the following components:
(A) 7.05-22.1% by weight of an anti-aging and anti-oxidant nutritional composition,
(B) optionally, ingredients commonly used in skin care cosmetics;
wherein the above percentage amounts comprise water, which is usually added as a separate component, calculated on the total weight of the cosmetic.
Preferably, the fullerene anti-aging antioxidant beauty and skin care cosmetic comprises: (A) 7.05-22.1% of anti-aging and anti-oxidation nutritional composition and (B) 92.95-77.9% of other ingredients commonly used in cosmetics.
Preferably, the anti-aging and anti-oxidation nutritional composition comprises:
preferably, (B) optionally, other ingredients commonly used for skin care cosmetics are cosmetic ingredients commonly used in the production of lotions, creams, masks, lotions or essences, and the skin care cosmetics may be lotions, creams, masks, lotions or essences depending on the commonly used ingredients.
The preparation method of the fullerene anti-aging antioxidant beauty and skin care cosmetic is characterized by comprising the following steps:
1) putting water-soluble substances into a water phase pot, putting oil-soluble substances into an oil phase pot, and respectively heating the water phase and the oil phase to 82-85 ℃; wherein, the raw materials which are easy to agglomerate are pre-dispersed by a disperser; after the dissolution is finished, conveying the oil phase and the water phase into a vacuum homogenizing and emulsifying pot, and homogenizing and emulsifying for about 5-15 minutes;
2) after emulsification is finished, continuously stirring and cooling, adding the anti-aging and anti-oxidation nutrition combination of fullerene when the temperature is reduced to 50 ℃, and continuously stirring and dispersing uniformly;
3) when the temperature is reduced to 45 ℃, adding the preservative, and stirring and dispersing uniformly;
4) when the temperature is reduced to 40 ℃, adding essence, and stirring and dispersing uniformly;
5) when the temperature is reduced to 38 ℃, adding the pH regulator component, stirring for 10-20 minutes, uniformly dispersing, and continuously cooling to room temperature;
6) supplementing the evaporated water, stirring, filtering, and discharging.
The anti-aging and anti-oxidation essence of fullerene comprises the following substances:
the invention has the beneficial effects that: the skin care product can obviously improve the effects of skin anti-aging, anti-oxidation, beauty and skin care products, and can greatly reduce the damage of free radicals to the skin of a human body, effectively delay the early aging of the skin, improve the skin moistening and moisturizing capability, enhance the skin elasticity, reduce the generation of fine wrinkles and young wrinkles, and simultaneously improve the skin color and luster. The anti-aging facial mask has the advantages of delaying skin aging, providing a scientific anti-aging nutritional combination for facial skin, keeping the facial skin moist, bright and elastic by insisting on using, reducing the generation of wrinkles and fine lines, and delaying the skin aging process.
Detailed Description
In order to facilitate an understanding of the present invention, a more complete description of the present invention is provided below. Preferred embodiments of the present invention are given below. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. Rather, these embodiments are provided so that this disclosure will be thorough and complete.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used herein in the description of the invention is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
The technical solution of the present patent will be described in further detail with reference to the following embodiments.
The invention provides a fullerene anti-aging antioxidant cosmetic for beauty and skin care and a preparation method thereof, and the invention is further explained in detail below in order to make the purpose, technical scheme and effect of the invention clearer and more clear. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
The fullerene is a substance formed by carbon with the same component, is a third allotrope in which simple substance carbon is found, and is divided into a series of fullerenes such as C60, C70, Gd @ C82 and the like according to the difference of the number of contained carbon atoms and the difference of embedded substances, wherein the fullerene applied in the cosmetic field is mainly C60 which is a three-dimensional hollow molecule formed by 60 carbon atoms, 12 five-membered rings and 20 six-membered rings and shaped like a football; fullerene was first produced in 1985 by three researchers, Harprod Wolter Crotto (Eng), Robert Keel (Mei), and Rickett Stomoli (Mei), who won the Nobel prize in 1996 for their discovery of fullerene. The research results of the last 30 years show that the metal fullerene inlaid on the wall of the tumor vessel can effectively destroy the tumor vessel when the nano particles explode, then quickly block the nutrient supply to the tumor, and completely starve the tumor cells within a few hours. Therefore, the metal fullerene embedded with Gd atoms is also called a molecular scalpel aiming at solid tumors.
Research also finds that fullerene has super-strong capability of eliminating free radicals of human bodies, strong and stable antioxidant effect, is recorded in an SFDA directory, has the antioxidant capability of 172 times that of VC and 50 times that of SOD, and is known as the king of oxidation resistance; in 6 months and 30 days in 2014, fullerene is formally recorded in catalog of names of used cosmetic raw materials by the State food and drug administration.
The fullerene has a core value in the field of beauty and skin care, fullerene-free radical killers, after the fullerene adsorbs free radicals, two adjacent free radicals adsorbed on the same covalent bond are combined by electrons to form a new compound and are separated from fullerene molecules, and after the free radicals are adsorbed by the fullerene molecules to form the new compound, the fullerene molecules have a complete structure and can continuously adsorb the free radicals.
Just because the fullerene has peculiar efficacy in the aspect of beauty and skin care, researches find that the fullerene is good in matching compatibility with other known cosmetic raw materials, and the beauty and skin care cosmetic with the functions of anti-aging and anti-oxidation can be developed by adopting scientific, organic and reasonable combination proportion, so that the fullerene is a fashionable product which is in line with perfect pursuit of the current market.
Agave stem extract, english name: AGAVEAMERICANASTTEMEXTRACT has the effects of moisturizing, relieving allergy, resisting ultraviolet rays and repairing skin.
Chitosamine, english name: acetylglucopamine, CAS No.: 7512-17-6, has excellent percutaneous absorbability, is a natural cutin regulator, can promote synthesis of hyaluronic acid of skin cells, and inhibit glycosylation of tyrosinase, thereby inhibiting tyrosinase maturation, reducing melanin synthesis, scavenging free radicals, reducing free radical injury to human body, removing wrinkle, resisting aging, and improving skin tissue repair ability.
Nicotinamide, the alias nicotinamide, CASNO: 98-92-0, application: vitamins are involved in metabolism in vivo, and can be used for preventing and treating niacin deficiency such as pellagra.
Phytosterol isostearate, english name: PHYTOSTERYLISOSTEARATE, CAS number: 83615-24-1, can strengthen the skin barrier, thereby protecting the skin from the external environment, greatly reduce the percutaneous water loss rate of the skin, have excellent repairing effect on the epidermis and dermis, and are high-efficiency skin moisturizers and emollients.
Palmitoyl pentapeptide-4, english name: palmitoylpentapeptide-4, CAS number 214047-00-4, purpose of use: the cosmetic polypeptide can penetrate dermis to increase hydrolyzed collagen, and reverse skin aging process through reconstruction from inside to outside; cosmetic pentapeptides are in fact hydrolyzed C-terminal fragments of collagen I, with efficacy similar to laser surgery; stimulating the proliferation of hydrolyzed collagen, elastic fiber and hyaluronic acid, improving the water content and water locking degree of skin, increasing the thickness of skin and reducing fine wrinkles; the absorption effect can be increased.
Acetyl hexapeptide-8, english name: acetylhexapeptide-8, CAS number: 616204-22-9, purpose of use: is a bioactive polypeptide, which can reduce existing facial wrinkles and effectively prevent new wrinkles. The release of the nerve conduction element acetylcholine (acetylcholine) is inhibited to reduce the contraction of muscles, thereby achieving the purpose of reducing the generation of dynamic lines and expression lines.
Hydrolyzed collagen, english name: hydrolyzed COLLAGEN, a small biological molecule, has effects in building up body, and making skin tender, smooth, firm and elastic; the activity of hydrolyzed collagen in the skin is enhanced, the metabolism of skin tissues is promoted, and good moistening, moisturizing, wrinkle-removing and beautifying effects are generated on the skin.
Centella asiatica extract: english name: centella asiaticaxtract, CASNO: 84696-21-9, the main active components of centella asiatica extract, asiaticoside and madecassoside, are widely used for removing scars and promoting wound healing.
The invention provides a fullerene anti-aging antioxidant cosmetic for beauty and skin care, which is prepared by scientifically and organically matching and combining fullerene, phytosterol isostearate, acetyl chitosamine, nicotinamide, hydrolyzed collagen, palmitoyl pentapeptide-4, acetyl hexapeptide-8, agave tongue (AGAVEAMERICANA) stem extract and centella asiatica (CENTELLAASIATICA) extract according to weight percentage and then placing the mixture into a known formula system of the cosmetic for refining. The key components playing a role in anti-aging care on facial skin are present in the fullerene nutrient composition, and the fullerene in the anti-aging and anti-oxidation effect composition has the effects of ultra-strong oxidation resistance and skin free radical elimination, and the damage of free radicals to human skin is greatly reduced, so that the beautifying and skin care effects are exerted, the proliferation of hydrolyzed collagen, elastic fibers and hyaluronic acid is stimulated, the water content and the water locking degree of the skin are improved, the skin thickness is increased, wrinkle fine lines are reduced, the skin aging is delayed, a scientific anti-aging nutrient composition is provided for the facial skin, the facial skin can be kept moist, bright and elastic after the facial skin is insisted for use, the generation of the wrinkle fine lines is reduced, and the skin aging process is delayed.
The fullerene anti-aging antioxidant beautifying and skin-care cosmetic composition optionally also comprises a component (B) which is a component commonly used in skin-care cosmetics and comprises a medium, an active component, auxiliary materials and the like. Component (B) is known in the art and can be specifically selected by those skilled in the art in terms of type and amount as desired. Typically, component (B) is present in the compositions of the present invention in an amount of from 92.95 to 77.9 weight percent, based on the total weight percent of the composition.
Such as diluents, dispersants or carriers, and the like. All these vehicles are known in the art and the type and amount thereof can be specifically selected by the skilled person as desired. For example, the vehicle includes water, surfactants and emulsifiers, thickeners, and the like;
such active ingredients include, for example, emollients, humectants, skin conditioning agents, and the like. All these active ingredients are known in the art and the type and amount thereof can be specifically selected by the skilled person as desired.
Such adjuvants include, for example, preservatives, fragrances, colorants, chelating agents, pH adjusters, all of which are known in the art, the type and amount of which can be specifically selected by one skilled in the art as desired.
The surfactant, which is used to reduce the surface tension of the interface for the purpose of cleaning, emulsifying, stabilizing the system, can be any type of surfactant commonly used in cosmetics, the type and amount of which can be selected by the skilled person as desired. For example, the surfactant may include, but is not limited to, fatty acid soaps (e.g., sodium laurate, sodium palmitate, etc.), higher alkyl sulfates (e.g., sodium lauryl sulfate, etc.), alkyl ether sulfates (e.g., PEG-triethanolamine lauryl sulfate, PEG-sodium lauryl sulfate, etc.), alkyl betaines, amido betaines, sulfobetaines, hydrogenated castor oil derivatives, glyceryl alkyl ethers, etc., PEG-glyceryl fatty acid esters (e.g., PEG-glyceryl monostearate, PEG-glyceryl monoisostearate, etc.), sucrose fatty acid esters, and the like. The amount of surfactant present in the composition is known in the art. Generally, the surfactant based on the total weight of the components in the compositions of the present invention will depend on the particular formulation.
For example, the emulsifier includes, but is not limited to, one or more of cetearyl olive oleate, sorbitan olive oleate, polysorbate-60, polysorbate-80, methylglucose sesquistearate, PEG-20 methylglucose sesquistearate, PEG-40 hydrogenated castor oil, PPG-26-buthylpolyether-26, steareth-2, steareth-21, cetearyl glucoside, PEG-100 stearate, glyceryl stearate SE, sucrose stearate, sucrose polystearate, and the like. The amount of the emulsifier in the composition is known in the art. Generally, the total weight of the emulsifier in the composition of the present invention is a function of the particular formulation.
For example, the thickener includes, but is not limited to, one or more of carbomers, acrylates and derivatives thereof, xanthan gum, hydroxyethyl cellulose, hydroxypropyl methyl cellulose, and like high molecular polymers. The amount of the thickener in the composition is known in the art. Generally, the thickener component content in the compositions of the present invention will depend on the particular formulation.
For example, the emollient includes, but is not limited to, one or more of olive oil, macadamia nut oil, sweet almond oil, grape seed oil, meadowfoam seed oil, jojoba seed oil, sunflower seed oil, squalane, ethylhexyl palmitate, isopropyl myristate, hydrogenated polyisobutene, isohexadecane, isododecane, diethylhexyl carbonate, dioctyl carbonate, isononyl isononanoate, hydrogenated polydecene, tris (ethylhexanoate) glyceride, cetyl ethylhexanoate, caprylic/capric triglyceride, octyldodecanol, polydimethylsiloxane, and the like. The solid emollient described herein includes, but is not limited to, one or more of cetyl alcohol, stearyl alcohol, cetostearyl alcohol, behenyl alcohol, batyl alcohol, lauric acid, myristic acid, palmitic acid, stearic acid, hydrogenated coconut oil glycerides, shea butter, saw palmetto seed fat, and the like. The amount of the emollient in the composition is known in the art. Generally, in the compositions of the present invention, is the emollient present in the total weight? It is required to be adjusted according to the characteristics of the product and the formula.
For example, the moisturizer includes, but is not limited to, one or more of glycerin, propylene glycol, 1, 3-propanediol, 1, 2-pentanediol, polyethylene glycol-8, polyethylene glycol-32, methyl gluceth-10, glycerol polyether-26, glycerol glucoside, PPG-10 methyl glucose ether, trehalose, rhamnose, mannose, raffinose, betaine, erythritol, sodium hyaluronate, sodium polyglutamate, hydrolyzed sclerotium gum, tremella polysaccharides, tamarind seed polysaccharides, and the like. The amount of the humectant in the composition is known in the art. Generally, how much of the total weight is the humectant in the compositions of the present invention? It is required to be adjusted according to the characteristics of the product and the formula.
The skin conditioner may include active ingredients for moisturizing, anti-wrinkle, spot removing, acne removing, oil control, etc., including, but not limited to, one or more of ascorbic acid, ascorbyl glucoside, arbutin, tranexamic acid, niacinamide, phytosterols, phenethyl resorcinol, turmeric root extract, white birch bark extract, ceramide 2, ceramide 3, resveratrol, Pterocarpus marsupium bark extract, pepper seed extract, ubiquinone, cholesterol, cholesteryl stearate, ascorbyl dipalmitate, tocopherol (vitamin E), tocopheryl acetate, bisabolol, ascorbyl tetraisopalmitate, retinol palmitate, phytosterol macadamia oleate, various peptides, various plant extracts, etc. The level of the skin conditioning agent in the composition is known in the art. Generally, how are conditioner ingredients selected in the compositions of the present invention? How much of the skin conditioning agent is based on total weight? It is required to be adjusted according to the characteristics of the product and the formula.
Such adjuvants include, but are not limited to, preservatives, fragrances, colorants, chelating agents, pH adjusting agents, and the like. All these auxiliary ingredients are known in the art and the type and amount thereof can be specifically selected by the skilled person as desired.
For example, the preservatives include, but are not limited to, one or more of methylparaben, propylparaben, phenoxyethanol, benzyl alcohol, phenylethyl alcohol, bis (hydroxymethyl) imidazolidinyl urea, potassium sorbate, sodium benzoate, chlorphenesin, sodium dehydroacetate, and the like. The amount of the preservative in the composition is known in the art. Generally, the preservative component content in the compositions of the present invention will depend on the particular formulation.
The aromatic comprises natural essence, artificial essence, essential oil, etc.
The colorant comprises carmine pigment (CI16255), brilliant blue 85 pigment (CI42090), lemon yellow 60 pigment (CI19140), sunset yellow 60 pigment (CI15985) and the like.
The chelating agent comprises disodium EDTA (EDTA-2Na), tetrasodium EDTA (EDTA-4Na) and the like.
Such pH adjusting agents include, but are not limited to, arginine, triethanolamine, citric acid, sodium citrate, sodium hydroxide, potassium hydroxide, and the like.
The fullerene anti-aging and anti-oxidation cosmetic for beautifying and protecting skin provided by the invention can be prepared by any suitable method known in the field. For example, it can be prepared by using a vessel such as a liquid washing pot, a vacuum homogenizing and emulsifying pot, a disperser, a transfer pump, etc., which are generally used in the field of cosmetics. The preparation method comprises putting water soluble substance into water phase pot, putting oil soluble substance into oil phase pot, respectively heating water phase and oil phase to about 85 deg.C, wherein the raw material easy to agglomerate can be pre-dispersed with disperser. After the dissolution is finished, conveying the oil phase and the water phase into a vacuum homogenizing and emulsifying pot, and homogenizing and emulsifying for about 5-15 minutes; after emulsification is finished, stirring and cooling are continued, fullerene anti-aging and anti-oxidation nutrition combination is added at 50 ℃, essence, preservative and the like are optionally added, the pH of the product is adjusted according to needs, stirring and cooling are continued, the temperature of the material body is reduced to normal temperature, and the material body can be filled and delivered after relevant detection indexes are qualified. The preparation method can be deleted or adjusted according to the requirements of the preparation formulation, and various preparation formulations such as emulsion, cream, facial mask, toner, essence and the like can be prepared according to the requirements.
The invention provides a fullerene anti-aging antioxidant beauty and skin care cosmetic, which is really a fullerene anti-aging nourishing beauty essence. It consists of the following substances:
in a preferred embodiment, the invention provides a fullerene anti-aging and anti-oxidation cosmetic and skin care cosmetic with the following formula, preferably fullerene anti-aging nourishing cosmetic essence, which shows excellent anti-aging and anti-oxidation, repairing and anti-allergy and enhances skin elasticity and is a good product for delaying skin aging.
TABLE 1
Weighing the raw materials corresponding to the examples according to the data in table 1, and preparing according to the following steps:
1) sequentially adding a P1 phase (water, glycerol, xanthan gum, ammonium acryloyldimethyl taurate/VP copolymer, sodium hyaluronate and EDTA-2Na) into a liquid washing pot, stirring and dispersing, heating to 82-85 ℃, keeping the temperature and stirring for 30-40 minutes, starting cooling water after solid phase substances are completely dissolved and dispersed, and adding a P2 phase (triethanolamine and adding a proper amount of water to dissolve in advance for later use) at 70 ℃;
2) cooling to 50 deg.C, adding P3 phase (fullerene, phytosterol isostearate, acetyl chitosamine, nicotinamide, hydrolyzed collagen, palmitoyl pentapeptide-4, acetyl hexapeptide-8, herba agaves Variegatae (AGAVE AMERICANA) stem extract, and herba Centellae (CENTELLA ASIATICA) extract), and stirring to disperse uniformly;
3) cooling to 45 deg.C, adding P4 phase (phenoxyethanol, 1, 3-butanediol, 1, 2-hexanediol, P-hydroxyacetophenone, and ethylhexylglycerin), stirring, and dispersing;
4) cooling to 40 deg.C, adding P5 phase (essence, PEG-40 hydrogenated castor oil, pre-dispersed for use), stirring for 10-20 min, dispersing, and cooling;
5) adding pH regulator (arginine and citric acid) when the temperature is reduced to 38 deg.C, stirring for 10-20 min, dispersing, and cooling to room temperature;
6) supplementing the evaporated water, stirring, filtering, and discharging.
The 1-4 fullerene anti-aging nourishing beauty essence prepared in the embodiment adopts a sensory evaluation method, and the specific implementation mode is as follows:
100 office workers (60 women, 22-45 years old; 40 men, 25-50 years old) were selected for testing, and the fullerene anti-aging nourishing beauty essence prepared in examples 1-4 was respectively used for testing 100 subjects. Smearing anti-aging, nourishing and beautifying fullerene essence once every morning and evening by a subject, and gently patting and massaging the skin by hands until the skin is completely absorbed; each example of the fullerene anti-aging nourishing beauty essence is continuously used for four weeks, the skin is graded according to the feelings of the testees, the grading is 10 minutes, 2 is the worst, 5 is the moderate, 10 is the best, the higher the grading is, the better the moisturizing, conditioning and anti-aging effects of the fullerene anti-aging nourishing essence are, the grading of 100 testees is 2-4 minutes before use, and the evaluation results of the effects of moisturizing, repairing, allergy, elasticity, skin tendering, wrinkle resistance and the like after use are shown in Table 2.
The invention provides fullerene anti-aging nourishing beauty essence which is prepared by adding mild and safe anti-aging and anti-oxidation nutrition combination into an essence formula, can effectively relieve and repair skin, reduce the generation of free radicals on the surface of the skin, resist the aging process of the skin and enhance the elasticity of the skin, and is proved by example tests to have quite good effect, and the fullerene anti-aging nourishing beauty essence is highly favored by tested users to continue using the fullerene anti-aging nourishing beauty essence.
TABLE 2
In a preferred embodiment, the present invention provides a fullerene anti-aging and anti-oxidation cosmetic skin care product, preferably a fullerene anti-aging skin rejuvenation cream, having the following formulation.
TABLE 3
In a preferred embodiment, the present invention provides a fullerene anti-aging antioxidant cosmetic for skin care having a formulation, preferably a fullerene anti-aging skin rejuvenation cream, which shows excellent anti-oxidation, reduction of skin wrinkle lines, enhancement of skin elasticity, and restoration of water-moist and silky youth of skin, as shown in table 3.
Weighing the raw materials corresponding to the examples according to the data in table 3, and preparing according to the following steps:
1) sequentially adding a P1 phase (water, 1, 3-butanediol, allantoin, EDTA-2Na, ammonium acryloyldimethyl taurate/VP copolymer and sodium hyaluronate) into a water phase pot, stirring and dispersing, heating to 82-85 ℃, keeping the temperature and stirring for 15-30 minutes, adding a P2 phase (cetostearyl alcohol, cetostearyl glucoside, glyceryl stearate, PEG-100 stearate, squalane, caprylic/capric triglyceride, isononyl isononanoate, Butyrospermum PARKII (Butyrum PARKII) fruit fat, hydrogenated coconut oil glycerides and sweet almond oil) into an oil phase pot, stirring and heating to 85 ℃, melting and dispersing a solid phase, and keeping the temperature for 10-20 minutes;
2) pumping the P1 and P2 phases into a vacuum mean value emulsifying pot, keeping the mean value for 5-15 minutes, stirring for 15 minutes for defoaming, then starting cooling water to cool, adding the P3 phases (water and arginine) at 65 ℃, keeping the mean value for 1-3 minutes, and continuing cooling and stirring;
3) cooling to 50 deg.C, adding P4 phase (fullerene, phytosterol isostearate, acetyl chitosamine, nicotinamide, hydrolyzed collagen, palmitoyl pentapeptide-4, acetyl hexapeptide-8, herba agaves Variegatae (AGAVE AMERICANA) stem extract, and herba Centellae (CENTELLA ASIATICA) extract), and stirring to disperse uniformly;
4) cooling to 45 deg.C, adding P5 phase (phenoxyethanol, P-hydroxyacetophenone, 1, 3-butanediol, 1, 2-hexanediol, ethylhexyl glycerol, and orange peel oil), stirring, dispersing, and cooling;
5) when the temperature is reduced to 38 ℃, the cooling water is closed to stop cooling;
6) supplementing the evaporated water, stirring, filtering, and discharging.
The 1-4 fullerene anti-aging skin-tendering cream prepared in the embodiment adopts a sensory evaluation method, and the specific implementation mode is as follows:
200 office workers (120 women, 20-55 years old; 80 men, 25-60 years old) were selected for testing, and the fullerene anti-aging skin-rejuvenating cream prepared as described in examples 1-4 was used for testing of 200 subjects, respectively. Smearing the anti-aging fullerene skin-tendering cream on a subject in the morning and at night each day, and gently massaging the subject with hands until the anti-aging fullerene skin-tendering cream is completely absorbed; each example of the fullerene anti-aging skin-tendering cream is continuously used for four weeks, a subject scores the skin-tendering cream according to own feelings, the score is 10 minutes, 2 is the worst score, 5 is the moderate score, 10 is the best score, the higher the score is, the better the anti-aging, anti-oxidation and anti-wrinkle effects of the fullerene anti-aging skin-tendering cream are achieved, the score is 2-4 minutes before the use of 200 subjects, and the evaluation results of the effects of moistening, moisturizing, allergy, elasticity, skin-tendering, anti-wrinkle and the like after the use are shown in Table 2.
TABLE 4
Examples of the invention | Moistening | Moisture retention | Allergy (S) | Elasticity | Light color | Anti-wrinkle | Results |
1 | 5 | 4 | 3 | 2 | 3 | 3 | 3.33 |
2 | 6 | 5 | 5 | 6 | 6 | 7 | 5.83 |
3 | 7 | 6 | 7 | 7 | 8 | 7 | 7.00 |
4 | 8 | 8 | 8 | 7 | 8 | 8 | 7.83 |
The invention provides a fullerene anti-aging skin-tendering cream which is prepared by adding mild and safe anti-aging and anti-oxidation nutrition combination into a high cream formula, can effectively relieve and repair skin, reduce the generation of free radicals on the surface of the skin, resist the aging process of the skin and enhance the elasticity of the skin, and is proved to have quite good effect by example test and is well accepted by tested users and is willing to continue to use the product.
In a preferred embodiment, the present invention provides a fullerene anti-aging antioxidant cosmetic for skin care, preferably a fullerene anti-aging skin rejuvenation mask having a formulation which shows excellent anti-aging antioxidant properties, fine wrinkle repair properties, and skin elasticity enhancement, and is a good mask for delaying skin aging.
TABLE 5
Weighing the raw materials corresponding to the examples according to the data in table 5, and preparing according to the following steps:
1) sequentially adding a P1 phase (water, glycerol, propylene glycol, xanthan gum, carbomer, sodium hyaluronate and EDTA-2Na) into a liquid washing pot, stirring for dispersion, heating to 82-85 ℃, keeping the temperature and stirring for 30-40 minutes, starting cooling water to cool after the solid phase is completely dissolved and dispersed, and adding a P2 phase (TEA, adding a proper amount of water and dissolving for later use);
2) cooling to 50 deg.C, adding P3 phase (fullerene, phytosterol isostearate, acetyl chitosamine, nicotinamide, hydrolyzed collagen, palmitoyl pentapeptide-4, acetyl hexapeptide-8, herba agaves Variegatae (AGAVE AMERICANA) stem extract, and herba Centellae (CENTELLA ASIATICA) extract), and stirring to disperse uniformly;
3) cooling to 45 deg.C, adding P4 phase (phenoxyethanol, butanediol, hexanediol, P-hydroxyacetophenone, and ethylhexyl glycerol), and stirring for dispersing;
4) cooling to 40 deg.C, adding P5 phase (essence, PEG-40 hydrogenated castor oil, pre-dispersed for use), stirring for 10-20 min, dispersing, and cooling;
5) adding pH regulator (arginine and citric acid) when the temperature is reduced to 38 deg.C, stirring for 10-20 min, dispersing, and cooling to room temperature;
6) supplementing the evaporated water, stirring, filtering, and discharging.
The yellow fullerene anti-aging skin-tendering mask is prepared by putting mask cloth into a bag, and then pouring essence and sealing, wherein the mask cloth is made of one of copper ammonia fiber, nano-Sael fiber, bamboo charcoal mask fiber, chitosan fiber and plant fiber.
The 1-4 fullerene anti-aging skin-tendering mask prepared in the embodiment is subjected to a sensory evaluation method, and the specific implementation mode is as follows:
100 office people (60 women, age 22-45 years; 40 men, age 25-50 years) were selected for testing, and the fullerene anti-aging skin-rejuvenating facial mask prepared as described in examples 1-4 was used for testing of 100 subjects, respectively. Smearing the fullerene anti-aging skin-tendering mask on a subject in the morning and at night every day, and gently patting and massaging the subject by hands until the fullerene anti-aging skin-tendering mask is completely absorbed; each example of the fullerene anti-aging and skin-tendering mask is continuously used for four weeks, the skin-tendering mask is graded by the testees according to the feelings of the testees, the grading is 10 minutes, 2 is the worst, 5 is the moderate, 10 is the best, the moisturizing and conditioning anti-aging effect of the fullerene anti-aging and skin-tendering mask is better when the grading is higher, the grading of 100 testees is 2-4 minutes before use, and the evaluation results of the effects of moisturizing, fine lines, allergy, elasticity, skin tendering, wrinkle resistance and the like after use are shown in Table 6.
The fullerene anti-aging skin-tendering mask provided by the invention is prepared by adding mild and safe anti-aging and anti-oxidation nutrition combination into a mask essence formula, can effectively relieve and nourish skin, reduce fine wrinkles, enhance skin elasticity and resist the skin aging process, and is proved to have quite good effect through example tests, and the fullerene anti-aging skin-tendering mask is highly favored by testees and is willing to continue to use the fullerene anti-aging skin-tendering mask.
TABLE 6
Examples | Moistening condition | Reduction of fine lines | Hypersensitivity to skin | Elasticity of skin | Brightening skin color | Anti-wrinkle condition | Conclusion |
1 | 5 | 5 | 5 | 5 | 4 | 5 | 4.83 |
2 | 5 | 6 | 5 | 6 | 5 | 6 | 5.5 |
3 | 7 | 7 | 6 | 7 | 6 | 8 | 6.83 |
4 | 8 | 8 | 9 | 7 | 8 | 8 | 8 |
In a preferred embodiment, the invention provides a fullerene anti-aging and anti-oxidation cosmetic skin care cosmetic with a formula, preferably fullerene anti-aging and anti-oxidation toner, which shows excellent anti-aging and anti-oxidation effects, skin tenderness, skin firming, pore shrinking and skin elasticity enhancing, and is a toner with the effect of delaying skin aging.
Weighing the raw materials corresponding to the examples according to the data in table 7, and preparing according to the following steps:
1) sequentially adding a P1 phase (water, glycerol, propylene glycol, sodium hyaluronate, EDTA-2Na) into a liquid washing pot, stirring and dispersing, heating to 82-85 ℃, preserving heat and stirring for 30-40 minutes, and starting cooling water after solid phase substances are completely dissolved and dispersed;
2) cooling to 50 deg.C, adding P2 phase (fullerene, phytosterol isostearate, acetyl chitosamine, nicotinamide, hydrolyzed collagen, palmitoyl pentapeptide-4, acetyl hexapeptide-8, herba agaves Variegatae (AGAVE AMERICANA) stem extract, and herba Centellae (CENTELLA ASIATICA) extract), and stirring to disperse uniformly;
3) cooling to 45 deg.C, adding P3 phase (phenoxyethanol, 1, 3-butanediol, 1, 2-hexanediol, P-hydroxyacetophenone, and ethylhexylglycerin), stirring, and dispersing;
4) cooling to 40 deg.C, adding P4 phase (essence, PEG-40 hydrogenated castor oil, pre-dispersed for use), stirring for 10-20 min, dispersing, and cooling;
5) adding pH regulator (arginine and citric acid) when the temperature is reduced to 38 deg.C, stirring for 10-20 min, dispersing, and cooling to room temperature;
6) supplementing the evaporated water, stirring, filtering, and discharging.
The 1-4 fullerene anti-aging firming toner prepared in the example is subjected to a sensory evaluation method, and the specific implementation mode is as follows:
100 office workers (60 women, 22-45 years old; 40 men, 25-50 years old) were selected for testing, and the fullerene anti-aging firming toner prepared as described in examples 1-4 was used for testing in 100 subjects, respectively. Smearing the anti-aging firming toner of the fullerene once in the morning and at night every day by a subject, and gently patting and massaging the skin by hands until the skin is completely absorbed; each example of the fullerene anti-aging compact toner is continuously used for four weeks, the skin of a subject is graded according to the self feeling, the grading is carried out by 10 minutes, 2 is the worst, 5 is the moderate, 10 is the best, the higher the grading is, the moisturizing, conditioning, elasticity, skin tendering and anti-aging effects of the fullerene anti-aging compact toner are better, the grading of 100 subjects before use is 2-4 minutes, and the evaluation results of the effects of moisturizing, fine lines, allergy, elasticity, skin tendering and anti-wrinkle are shown in Table 8.
TABLE 8
Examples | Moistening condition | Tender skin | Hypersensitivity to skin | Elasticity of skin | Firming skin | Anti-wrinkle condition | Conclusion |
1 | 5 | 4 | 3 | 3 | 4 | 4 | 3.83 |
2 | 6 | 6 | 5 | 6 | 5 | 6 | 5.67 |
3 | 6 | 7 | 7 | 7 | 7 | 7 | 6.83 |
4 | 8 | 8 | 8 | 8 | 8 | 7 | 7.83 |
The fullerene anti-aging firming toner provided by the invention is prepared by adding mild and safe anti-aging and anti-oxidation nutrition combination into a toner formula, can effectively relax and nourish the skin, firms the skin, enhances the skin elasticity and resists the skin aging process, and the effect is proved to be quite good by example tests, so that the fullerene anti-aging firming toner is highly favored by testees to continue using the fullerene anti-aging firming toner.
In a preferred embodiment, the present invention provides a fullerene anti-aging antioxidant cosmetic skin care cosmetic with a formulation, preferably fullerene anti-aging nourishing skin rejuvenating cream, which shows excellent anti-oxidation, reduction of skin wrinkle fine lines, enhancement of skin elasticity, reduction of skin sagging, and restoration of your firm and alive healthy skin, as shown in table 9.
TABLE 9
The raw materials corresponding to the examples were weighed according to the data in table 9, and prepared according to the following steps:
3) sequentially adding a P1 phase (water, 1, 3-butanediol, glycerol, allantoin, EDTA-2Na, ammonium acryloyldimethyl taurate/VP copolymer and sodium hyaluronate) into a water phase pot, stirring and dispersing, heating to 82-85 ℃, keeping the temperature and stirring for 15-30 minutes, adding a P2 phase (cetostearyl alcohol, glyceryl stearate, PEG-100 stearate, olive oil, caprylic/capric triglyceride, isononyl isononanoate, shea butter (Butyripenum Parkii) fruit fat, hydrogenated polyisobutene and tocopheryl acetate) into an oil phase pot, stirring and heating to 85 ℃, melting and dispersing a solid phase, and keeping the temperature for 10-20 minutes;
4) pumping the P1 and P2 phases into a vacuum mean value emulsifying pot, keeping the mean value for 5-15 minutes, stirring for 15 minutes for defoaming, then starting cooling water to cool, adding the P3 phases (water and arginine) at 65 ℃, keeping the mean value for 1-3 minutes, and continuing cooling and stirring;
3) cooling to 50 deg.C, adding P4 phase (fullerene, phytosterol isostearate, acetyl chitosamine, nicotinamide, hydrolyzed collagen, palmitoyl pentapeptide-4, acetyl hexapeptide-8, herba agaves Variegatae (AGAVE AMERICANA) stem extract, and herba Centellae (CENTELLA ASIATICA) extract), and stirring to disperse uniformly;
4) cooling to 45 deg.C, adding P5 phase (phenoxyethanol, menthone, 1, 3-butanediol, 1, 2-hexanediol, ethylhexyl glycerol, and Rosa CANINA (Rosa CANINA) fruit oil), stirring, dispersing, and cooling;
5) when the temperature is reduced to 38 ℃, the cooling water is closed to stop cooling;
7) supplementing the evaporated water, stirring, filtering, and discharging.
The 1-4 fullerene anti-aging nourishing and skin-tendering milk prepared in the embodiment adopts a sensory evaluation method, and the specific implementation mode is as follows:
200 office workers (120 women, 20-55 years old; 80 men, 25-60 years old) were selected for testing, and the fullerene anti-aging nourishing and skin-tendering creams prepared as described in examples 1-4 were respectively tested for 200 subjects. Smearing fullerene anti-aging nourishing skin-tendering emulsion on a subject in the morning and at night every day, and gently massaging the subject with hands until the fullerene anti-aging nourishing skin-tendering emulsion is completely absorbed; each example of the fullerene anti-aging nourishing and skin-tendering lotion is continuously used for four weeks, the skin-reviving lotion is graded by the test subjects according to the feelings of the test subjects, the grading is 10 minutes, 2 is the worst, 5 is the moderate, 10 is the best, the skin-moisturizing, relaxing, compacting, elasticity and anti-wrinkle effects of the fullerene anti-aging nourishing and skin-tendering lotion are better when the grading is higher, the grading before the use of 200 test subjects is 2-4 minutes, and the evaluation results of the effects of moisturizing, relaxing, allergy, elasticity, compacting and anti-wrinkle after the use are shown in the table 10.
Watch 10
The fullerene anti-aging nourishing skin-tendering lotion provided by the invention is prepared by adding mild and safe anti-aging and anti-oxidation nutrition combination into a lotion formula, can effectively relax and nourish skin, compact skin, enhance skin elasticity and resist the process of skin relaxation and aging, and is proved to have quite good effect through example test, so that the lotion is highly favored by testees to continue using the lotion.
The technical solutions of the above-described embodiments are preferred embodiments of the present invention, and several modifications and changes can be made without departing from the principle of the present invention, and these modifications and changes should also be considered as being within the protection scope of the present invention.
Claims (7)
1. The fullerene anti-aging antioxidant cosmetic for beauty and skin care is characterized by comprising the following components:
(A) 7.05-22.1% by weight of an anti-aging and anti-oxidant nutritional composition,
(B) optionally, ingredients commonly used in skin care cosmetics;
wherein the above percentage amounts comprise water, which is usually added as a separate component, calculated on the total weight of the cosmetic.
2. The fullerene anti-aging antioxidant cosmetic for beauty and skin care according to claim 1, comprising: (A) 7.05-22.1% of anti-aging and anti-oxidation nutritional composition and (B) 92.95-77.9% of other ingredients commonly used in cosmetics.
4. the fullerene anti-aging antioxidant cosmetic for skin care of claim 1 or 2, wherein the (B) optional, other ingredients commonly used for skin care cosmetics are cosmetic ingredients commonly used in the production of lotions, creams, masks, lotions or essences.
5. The preparation method of the fullerene anti-aging antioxidant beauty and skin care cosmetic is characterized by comprising the following steps:
1) putting water-soluble substances into a water phase pot, putting oil-soluble substances into an oil phase pot, and respectively heating the water phase and the oil phase to 82-85 ℃; wherein, the raw materials which are easy to agglomerate are pre-dispersed by a disperser; after the dissolution is finished, conveying the oil phase and the water phase into a vacuum homogenizing and emulsifying pot, and homogenizing and emulsifying for about 5-15 minutes;
2) after emulsification is finished, continuously stirring and cooling, adding the anti-aging and anti-oxidation nutrition combination of fullerene when the temperature is reduced to 50 ℃, and continuously stirring and dispersing uniformly;
3) when the temperature is reduced to 45 ℃, adding the preservative, and stirring and dispersing uniformly;
4) when the temperature is reduced to 40 ℃, adding essence, and stirring and dispersing uniformly;
5) when the temperature is reduced to 38 ℃, adding the pH regulator component, stirring for 10-20 minutes, uniformly dispersing, and continuously cooling to room temperature;
6) supplementing the evaporated water, stirring, filtering, and discharging.
7. the fullerene anti-aging and anti-oxidation beauty and skin care cosmetic as claimed in claim 6, which is essence.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911385056.2A CN111166683A (en) | 2019-12-28 | 2019-12-28 | Fullerene anti-aging antioxidant beauty and skin care cosmetic and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911385056.2A CN111166683A (en) | 2019-12-28 | 2019-12-28 | Fullerene anti-aging antioxidant beauty and skin care cosmetic and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111166683A true CN111166683A (en) | 2020-05-19 |
Family
ID=70624586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911385056.2A Pending CN111166683A (en) | 2019-12-28 | 2019-12-28 | Fullerene anti-aging antioxidant beauty and skin care cosmetic and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111166683A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111529427A (en) * | 2020-06-15 | 2020-08-14 | 溯源生命科技股份有限公司 | Active polypeptide compound plant extract anti-aging repair composition, application and essence milk containing composition |
CN113208968A (en) * | 2021-05-24 | 2021-08-06 | 杭州诺诚洗涤科技有限公司 | Whitening and moisturizing essence and preparation method thereof |
CN113440451A (en) * | 2021-07-21 | 2021-09-28 | 广州德贝芙生物科技有限公司 | Anti-aging composition |
CN114259419A (en) * | 2021-12-29 | 2022-04-01 | 河北纳科生物科技有限公司 | Compound composition containing recombinant collagen and preparation method and application thereof |
CN114404308A (en) * | 2021-12-01 | 2022-04-29 | 广州雷诺生物科技有限公司 | Fullerene moisturizing, whitening and repairing essence and preparation method thereof |
CN114515263A (en) * | 2022-03-01 | 2022-05-20 | 蓝芳曲 | Soothing, repairing, moisturizing and skin cleansing cream and preparation method thereof |
CN114652628A (en) * | 2022-03-30 | 2022-06-24 | 广州腾麟生物科技有限公司 | Anti-aging cream for beautifying chest and body and enhancing skin immune barrier and preparation method thereof |
CN115120513A (en) * | 2021-03-29 | 2022-09-30 | 苏州北科纳米科技有限公司 | MXene anti-aging and anti-oxidation skin care product and preparation method thereof |
CN115429712A (en) * | 2022-09-02 | 2022-12-06 | 广东粤港澳大湾区国家纳米科技创新研究院 | Polypeptide and fullerene co-delivery nano composition, preparation method and application thereof |
CN115670992A (en) * | 2022-09-06 | 2023-02-03 | 南京天其美生物技术有限公司 | Herbal peritoneal membrane for gestation repair and preparation method thereof |
CN117224424A (en) * | 2023-09-08 | 2023-12-15 | 广州暨科医药有限公司 | Whitening, tightening and repairing freeze-dried powder and preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106420445A (en) * | 2016-09-19 | 2017-02-22 | 广东丸美生物技术股份有限公司 | Skin care matrix with moisture preserving and oxidation resisting effects as well as preparation method and application of skin care matrix |
CN108014043A (en) * | 2017-12-15 | 2018-05-11 | 广东盛美化妆品有限公司 | A kind of maintenance frost of the Herba Dendrobii extract containing iron sheet and preparation method thereof |
CN109589297A (en) * | 2019-01-09 | 2019-04-09 | 广州灵润生物科技有限公司 | A kind of fullerene sodium hyaluronate polypeptide MASQUE APAISANT HYDRATANT |
-
2019
- 2019-12-28 CN CN201911385056.2A patent/CN111166683A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106420445A (en) * | 2016-09-19 | 2017-02-22 | 广东丸美生物技术股份有限公司 | Skin care matrix with moisture preserving and oxidation resisting effects as well as preparation method and application of skin care matrix |
CN108014043A (en) * | 2017-12-15 | 2018-05-11 | 广东盛美化妆品有限公司 | A kind of maintenance frost of the Herba Dendrobii extract containing iron sheet and preparation method thereof |
CN109589297A (en) * | 2019-01-09 | 2019-04-09 | 广州灵润生物科技有限公司 | A kind of fullerene sodium hyaluronate polypeptide MASQUE APAISANT HYDRATANT |
Non-Patent Citations (2)
Title |
---|
MC酵素减肥日记: "佩兰多肽修护⾯面膜功能成分介绍", 《HTTPS://WWW.SOHU.COM/A/274601513_596309》 * |
惠州唤美肌电子商务有限公司: "唤美肌涂抹式水光精华液,备案编号:粤G妆网备字2017179606", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/FW/PZ.JSP?PROCESSID=20171117151849HFU3F&NID=20171117151849HFU3F》 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111529427A (en) * | 2020-06-15 | 2020-08-14 | 溯源生命科技股份有限公司 | Active polypeptide compound plant extract anti-aging repair composition, application and essence milk containing composition |
CN115120513A (en) * | 2021-03-29 | 2022-09-30 | 苏州北科纳米科技有限公司 | MXene anti-aging and anti-oxidation skin care product and preparation method thereof |
CN113208968A (en) * | 2021-05-24 | 2021-08-06 | 杭州诺诚洗涤科技有限公司 | Whitening and moisturizing essence and preparation method thereof |
CN113208968B (en) * | 2021-05-24 | 2022-04-22 | 北京美丽臻颜化妆品有限公司 | Whitening and moisturizing essence and preparation method thereof |
CN113440451A (en) * | 2021-07-21 | 2021-09-28 | 广州德贝芙生物科技有限公司 | Anti-aging composition |
CN114404308A (en) * | 2021-12-01 | 2022-04-29 | 广州雷诺生物科技有限公司 | Fullerene moisturizing, whitening and repairing essence and preparation method thereof |
CN114259419A (en) * | 2021-12-29 | 2022-04-01 | 河北纳科生物科技有限公司 | Compound composition containing recombinant collagen and preparation method and application thereof |
CN114515263A (en) * | 2022-03-01 | 2022-05-20 | 蓝芳曲 | Soothing, repairing, moisturizing and skin cleansing cream and preparation method thereof |
CN114652628A (en) * | 2022-03-30 | 2022-06-24 | 广州腾麟生物科技有限公司 | Anti-aging cream for beautifying chest and body and enhancing skin immune barrier and preparation method thereof |
CN115429712A (en) * | 2022-09-02 | 2022-12-06 | 广东粤港澳大湾区国家纳米科技创新研究院 | Polypeptide and fullerene co-delivery nano composition, preparation method and application thereof |
CN115429712B (en) * | 2022-09-02 | 2024-01-23 | 广东粤港澳大湾区国家纳米科技创新研究院 | Polypeptide and fullerene co-delivery nano composition, and preparation method and application thereof |
CN115670992A (en) * | 2022-09-06 | 2023-02-03 | 南京天其美生物技术有限公司 | Herbal peritoneal membrane for gestation repair and preparation method thereof |
CN117224424A (en) * | 2023-09-08 | 2023-12-15 | 广州暨科医药有限公司 | Whitening, tightening and repairing freeze-dried powder and preparation method and application thereof |
CN117224424B (en) * | 2023-09-08 | 2024-03-08 | 广州暨科医药有限公司 | Whitening, tightening and repairing freeze-dried powder and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111166683A (en) | Fullerene anti-aging antioxidant beauty and skin care cosmetic and preparation method thereof | |
JP6608561B2 (en) | Skin care cosmetic composition | |
KR102265730B1 (en) | cosmetic composition for skin wrinkle improvement and whitening facial skin | |
TW202114621A (en) | Double-dosage-form moisturizing essence and preparation method thereof | |
CN108478497B (en) | Deep moisturizing composition and application thereof in skin care products | |
KR101810231B1 (en) | Cosmetic composition for improving acne containing propolis spicule powder | |
CN110664689A (en) | Eye cream preparation with flexible nano-liposome as carrier and preparation method thereof | |
CN109106677B (en) | A kind of composition with whitening function and application thereof | |
CN113693962A (en) | Fibronectin-containing multiple protein repair composition and preparation method thereof | |
WO2008139182A2 (en) | Skin care composition | |
JPH11228339A (en) | Melanin generation suppresser and preparation for external use for skin | |
KR102142311B1 (en) | Skin external composition comprising tangeretin | |
CN110787088A (en) | Basic composition for lip wrinkle fading and preparation method and application thereof | |
US20220378690A1 (en) | Compositions and methods for treating skin | |
CN109330954B (en) | Whitening skin brightening lotion, preparation method thereof and tyrosinase inhibitor | |
CN114983840A (en) | Skin barrier repairing composition capable of resisting external stimulation | |
CN115721595A (en) | Body lotion and preparation method thereof | |
CN110721148A (en) | Multidirectional pulling and tightening polypeptide essence and preparation method thereof | |
CN114099410B (en) | Face cream composition of liposome with synergistic gain and anti-aging effects and preparation method thereof | |
JP3791775B2 (en) | Topical skin preparation | |
JPH09221410A (en) | Aging preventing skin ointment | |
KR20110052095A (en) | Cosmetic composition for moisturizing skin containing mushroom extract | |
CN114748394A (en) | Makeup removing cream and preparation method thereof | |
KR20120139222A (en) | Composition for skin external application comprising tanshinone iia as the active ingredient | |
KR101862039B1 (en) | A cosmetic composition containing spicule powder and natural complex extract stabilized in nanoliposome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200519 |